Clinical Trials Logo

Second Trimester Abortion clinical trials

View clinical trials related to Second Trimester Abortion.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04063904 Terminated - Clinical trials for Second Trimester Abortion

Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia

Start date: October 16, 2019
Phase: Phase 4
Study type: Interventional

This pilot study seeks to evaluate the safety, acceptability and feasibility of a shortened outpatient procedure for medical abortion at 13-18 weeks gestation. It also seeks to document the roles of health workers in providing services related to later abortion care. Participants will take a single dose of 200 mg mifepristone orally, followed 24-48 hours later with 400 mcg misoprostol sublingually prior to arriving at the study clinic. Repeat doses of 400 mcg misoprostol will be administered sublingually every three hours at the clinic until the abortion is achieved. If expulsion does not occur by a certain time prior to the clinic closing that day, D&E will be performed to complete the abortion.

NCT ID: NCT03714880 Terminated - Clinical trials for Second Trimester Abortion

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

Start date: April 26, 2019
Phase: Phase 2
Study type: Interventional

The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D&E) procedures.